
Ulrike H Ziegner MD PhD
Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions
Riviera Allergy Medical Center
Join to view full profile
1970 South Prospect AveSte #3Redondo Beach, CA 90277
Phone+1 310-792-9050
Fax+1 310-792-9048
Dr. Ziegner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterPost-Doctoral Fellowship, Allergy and Immunology, 1999 - 1999
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Allergy/Immunology, 1997 - 1999
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1994 - 1997
UPMC Childrens Hospital of Pittsburgh Primary Care CenterPost-Doctoral Fellowship, 1987 - 1991
Internal MedicineResidency, Department of Cardiology and Department of Oncology/Immunology, 1985 - 1987
Certifications & Licensure
CA State Medical License 1996 - 2028
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ADP AdvancedMD EHR, AdvancedMD, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2012, 2014, 2016-2017
Clinical Trials
- A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma
- Efficacy and Safety of Two Dry Power Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma
- A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy
Publications & Presentations
PubMed
- 34 citationsNatural killer cell-mediated lysis of T cell lines chronically infected with HIV-1.Santu Bandyopadhyay, Ulrike Ziegner, Dianne E. Campbell, D S Miller, James A. Hoxie
Clinical and Experimental Immunology. 2008-06-28 - 50 citationsProgressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment.Ulrike H.M. Ziegner, Roger H. Kobayashi, Charlotte Cunningham-Rundles, Teresa Espanol, Anders Fasth
Clinical Immunology. 2002-01-01 - 31 citationsUnrelated umbilical cord stem cell transplantation for X-linked immunodeficienciesUlrike H.M. Ziegner, Hans D. Ochs, Carolyn Schanen, Stephen A. Feig, Kuniaki Seyama
The Journal of Pediatrics. 2001-04-01
Professional Memberships
- Fellow
Other Languages
- French, German, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









